American International Group Raised Lazard LTD Cl A (LAZ) Stake; Meridian Bioscience (VIVO) Has 1.62 Sentiment

August 10, 2018 - By Matthew Richard

Lazard Ltd (NYSE:LAZ) Logo

Meridian Bioscience Inc (VIVO) investors sentiment increased to 1.62 in 2018 Q1. It’s up 0.42, from 1.2 in 2017Q4. The ratio has improved, as 89 institutional investors increased and started new holdings, while 55 reduced and sold their equity positions in Meridian Bioscience Inc. The institutional investors in our database now possess: 36.20 million shares, down from 36.52 million shares in 2017Q4. Also, the number of institutional investors holding Meridian Bioscience Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 10 Reduced: 45 Increased: 61 New Position: 28.

American International Group Inc increased Lazard Ltd Cl A (LAZ) stake by 608.8% reported in 2018Q1 SEC filing. American International Group Inc acquired 16,748 shares as Lazard Ltd Cl A (LAZ)’s stock declined 0.24%. The American International Group Inc holds 19,499 shares with $1.03M value, up from 2,751 last quarter. Lazard Ltd Cl A now has $6.26 billion valuation. The stock decreased 0.36% or $0.19 during the last trading session, reaching $52.26. About 254,971 shares traded. Lazard Ltd (NYSE:LAZ) has risen 25.31% since August 10, 2017 and is uptrending. It has outperformed by 12.74% the S&P500. Some Historical LAZ News: 19/03/2018 – LAZARD BOUGHT 9.73M TURK TELEKOM SHRS; RAISING STAKE TO 5.26%; 26/04/2018 – LAZARD LTD – ASSET MANAGEMENT OPERATING REVENUE WAS A FIRST-QUARTER RECORD OF $330 MILLION FOR 2018, 18% HIGHER THAN FIRST QUARTER OF 2017; 11/04/2018 – Peter Q. Thompson Joins Lazard Midwest Advisory Team; 14/05/2018 – Lazard Asset Buys New 3% Position in Cohu; 25/04/2018 – LAZARD BOOSTS QTRLY DIV TO 44C-SHR FROM 41C, EST. 45C; 27/04/2018 – LAZARD LTD LAZ.N : KBW RAISES TARGET PRICE TO $69 FROM $67; 09/04/2018 – SABESP: LAZARD NOTE ON TOTAL CLIENTS PORTFOLIO MANAGED BY CO; 14/05/2018 – Lazard Asset Buys New 2.2% Position in Aptiv; 20/03/2018 – MOZAMBIQUE WON’T REACH PRIMARY BALANCE UNTIL 2022: LAZARD; 30/04/2018 – Lazard Sees Comeback in Pharma Mega-Deals After Decade’s Respite

Brown Capital Management Llc holds 0.65% of its portfolio in Meridian Bioscience, Inc. for 4.01 million shares. Connors Investor Services Inc owns 187,165 shares or 0.39% of their US portfolio. Moreover, Ronna Sue Cohen has 0.38% invested in the company for 36,376 shares. The New York-based Lucus Advisors Llc has invested 0.37% in the stock. Systematic Financial Management Lp, a New Jersey-based fund reported 1.02 million shares.

Meridian Bioscience, Inc., a life science company, develops, makes, distributes, and sells diagnostic test kits primarily for various gastrointestinal, viral, respiratory, and parasitic infectious diseases worldwide. The company has market cap of $635.16 million. The firm operates through Diagnostics and Life Science divisions. It has a 26.32 P/E ratio. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the illumigene brand; rapid immunoassays, a single-use immunoassays that can be used in point-of-care settings under the TRU, ImmunoCard, and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the Premier brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare brand.

The stock increased 1.18% or $0.18 during the last trading session, reaching $15. About 106,662 shares traded. Meridian Bioscience, Inc. (VIVO) has risen 6.09% since August 10, 2017 and is uptrending. It has underperformed by 6.48% the S&P500. Some Historical VIVO News: 16/04/2018 – Meridian Energy Group, Inc. Signs Letter of Intent with Leading EPC Solutions Provider for Front End Engineering and Design Services; 30/05/2018 – MFS Meridian Funds – European Research Fund Adds CYBG; 14/05/2018 – Meridian Energy: April Retail Sales Volume Down 0.6% From April 2017; 05/03/2018 – MFS Meridian Funds – European Value Fund Cuts Danone; 21/03/2018 – MERIDIAN BIOSCIENCE INC – LIFE SCIENCE BUSINESS UNIT CONSISTS OF IMMUNOLOGICAL REAGENTS AND MOLECULAR REAGENTS; 23/04/2018 – WARREN EQUITY REPORTS PURCHASE OF MERIDIAN WASTE; 16/04/2018 – Meridian Waste Solutions’ Attis Innovations to Attend and Present at Premier Biomass Processing Conference; 12/04/2018 – Hutchinson Clinic Selects Meridian Medical Management for Revenue Cycle Management; 16/04/2018 – Meridian Waste Solutions’ Attis Innovations to Attend and Present at Premier Biomass Processing Conference; 14/03/2018 – Meridian Waste Solutions’ Attis Innovations Strikes Partnerships in Florida to Create Biomass Value from Rogued Citrus Trees and Byproducts

Since January 1, 0001, it had 1 buying transaction, and 0 selling transactions for $14,034 activity.

More recent Meridian Bioscience, Inc. (NASDAQ:VIVO) news were published by: Nasdaq.com which released: “Meridian Bioscience Reports Third Quarter 2018 Operating Results, Declares Regular Third Quarter Cash Dividend …” on July 31, 2018. Also Nasdaq.com published the news titled: “Quartzy joins with Bioline, Biotium, and MP Biomedicals to create the most diverse digital catalog of lab supplies in the …” on July 24, 2018. Streetinsider.com‘s news article titled: “Meridian Bioscience (VIVO) Reports In-Line Q3 EPS, Miss on Revenues; Affirms Fiscal 2018 Guidance” with publication date: July 31, 2018 was also an interesting one.

Analysts await Meridian Bioscience, Inc. (NASDAQ:VIVO) to report earnings on November, 8. They expect $0.16 earnings per share, up 6.67% or $0.01 from last year’s $0.15 per share. VIVO’s profit will be $6.78M for 23.44 P/E if the $0.16 EPS becomes a reality. After $0.18 actual earnings per share reported by Meridian Bioscience, Inc. for the previous quarter, Wall Street now forecasts -11.11% negative EPS growth.

American International Group Inc decreased Brinker International Inc (NYSE:EAT) stake by 16,613 shares to 121,518 valued at $4.39 million in 2018Q1. It also reduced Churchill Downs Inc (NASDAQ:CHDN) stake by 4,539 shares and now owns 31,080 shares. Corning Inc (NYSE:GLW) was reduced too.

More news for Lazard Ltd (NYSE:LAZ) were recently published by: Businesswire.com, which released: “Michael Skelly Joins Lazard as a Senior Advisor” on August 09, 2018. Seekingalpha.com‘s article titled: “Lazard (LAZ) Q2 2018 Results – Earnings Call Transcript” and published on July 26, 2018 is yet another important article.

Among 3 analysts covering Lazard Ltd (NYSE:LAZ), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Lazard Ltd had 3 analyst reports since April 12, 2018 according to SRatingsIntel. The rating was upgraded by Bank of America to “Buy” on Tuesday, April 17. The stock has “Buy” rating by Sandler O’Neill on Thursday, April 12. As per Friday, April 27, the company rating was maintained by JMP Securities.

Since March 1, 2018, it had 0 insider buys, and 2 insider sales for $4.24 million activity. 65,160 Lazard Ltd (NYSE:LAZ) shares with value of $3.46 million were sold by Stern Alexander F.. Hoffman Scott D also sold $781,950 worth of Lazard Ltd (NYSE:LAZ) on Thursday, March 1.

Investors sentiment increased to 1.13 in Q1 2018. Its up 0.13, from 1 in 2017Q4. It improved, as 25 investors sold LAZ shares while 96 reduced holdings. 48 funds opened positions while 89 raised stakes. 87.57 million shares or 0.14% less from 87.70 million shares in 2017Q4 were reported. Mufg Americas Holdg holds 0.01% or 6,095 shares. Voya Ltd Limited Liability Company stated it has 0.3% of its portfolio in Lazard Ltd (NYSE:LAZ). Northwestern Mutual Wealth has 1,131 shares for 0% of their portfolio. Mackenzie holds 39,873 shares or 0.01% of its portfolio. Susquehanna Grp Inc Limited Liability Partnership holds 0% or 63,267 shares in its portfolio. Evanson Asset Management Ltd Liability Company reported 0.26% of its portfolio in Lazard Ltd (NYSE:LAZ). Murphy Pohlad Asset Mngmt Lc reported 24,675 shares or 0.89% of all its holdings. Moreover, Utah Retirement Systems has 0.02% invested in Lazard Ltd (NYSE:LAZ). Sandler Cap Management reported 72,440 shares stake. Middleton & Company Ma invested in 0.17% or 18,230 shares. Royal Bank Of Scotland Grp Public Lc owns 17,195 shares for 0.19% of their portfolio. Cambiar Limited Liability Corporation holds 0.01% of its portfolio in Lazard Ltd (NYSE:LAZ) for 8,563 shares. State Teachers Retirement System has 10,600 shares for 0% of their portfolio. Florida-based Provise Gru Ltd Liability Corporation has invested 0.04% in Lazard Ltd (NYSE:LAZ). The Tennessee-based Highland Cap Mgmt has invested 0.06% in Lazard Ltd (NYSE:LAZ).

Meridian Bioscience, Inc. (NASDAQ:VIVO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts